BNT162b2 mRNA新冠疫苗第二剂与既往感染过SARS-CoV-2的患者心脏受累之间的时间关系。 - Suppr

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection.

作者信息

Ammirati Enrico, Cavalotti Cristina, Milazzo Angela, Pedrotti Patrizia, Soriano Francesco, Schroeder Jan W, Morici Nuccia, Giannattasio Cristina, Frigerio Maria, Metra Marco, Camici Paolo G, Oliva Fabrizio

机构信息

"De Gasperis" Cardio Center, Niguarda Hospital, Milan, Italy.

Unit of Allergology and Immunology, Niguarda Hospital, Milan, Italy.

出版信息

Int J Cardiol Heart Vasc. 2021 Jun;34:100774. doi: 10.1016/j.ijcha.2021.100774. Epub 2021 Mar 31.

DOI:10.1016/j.ijcha.2021.100774

PMID:33821210

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8011690/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b44/8065187/8c5e0bea0545/gr1.jpg

相似文献

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection.

Int J Cardiol Heart Vasc. 2021 Jun;34:100774. doi: 10.1016/j.ijcha.2021.100774. Epub 2021 Mar 31.

Temporal Relation Between Second Dose BNT162b2 mRNA Covid-19 Vaccine and Cardiac involvement in a Patient with Previous SARS-COV-2 Infection.

Int J Cardiol Heart Vasc. 2021 Apr 5:100778. doi: 10.1016/j.ijcha.2021.100778.

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.

Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015. Epub 2021 Feb 2.

Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccine.

medRxiv. 2021 Feb 5:2021.02.03.21251078. doi: 10.1101/2021.02.03.21251078.

Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.

Front Immunol. 2021 Mar 12;12:657711. doi: 10.3389/fimmu.2021.657711. eCollection 2021.

[Current state of vaccination against SARS-CoV-2].

Z Rheumatol. 2021 Mar;80(2):158-164. doi: 10.1007/s00393-021-00966-9. Epub 2021 Feb 2.

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines.

Vaccines (Basel). 2021 Mar 5;9(3):227. doi: 10.3390/vaccines9030227.

COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.

Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.

Viruses. 2021 Jan 14;13(1):109. doi: 10.3390/v13010109.

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses.

bioRxiv. 2021 Mar 18:2021.03.18.435972. doi: 10.1101/2021.03.18.435972.

引用本文的文献

The Epidemiology of COVID-19 Vaccine-Induced Myocarditis.

Adv Med. 2024 Apr 18;2024:4470326. doi: 10.1155/2024/4470326. eCollection 2024.

COVID-19 mRNA vaccine-related myocarditis: A PRISMA systematic review, imaging approach and differential diagnoses.

Radiol Case Rep. 2023 Dec 22;19(3):1008-1019. doi: 10.1016/j.radcr.2023.11.070. eCollection 2024 Mar.

Effect of SARS-CoV-2 Infection and BNT162b2 Vaccination on the mRNA Expression of Genes Associated with Angiogenesis.

Int J Mol Sci. 2023 Nov 8;24(22):16094. doi: 10.3390/ijms242216094.

Cardiovascular Disease and COVID-19 Vaccines: A Systematic Review and Analysis of Published Cases.

Eur Cardiol. 2023 Sep 13;18:e54. doi: 10.15420/ecr.2023.01. eCollection 2023.

Delayed presentation of biopsy-proven eosinophilic myocarditis following COVID-19 mRNA vaccine.

Glob Cardiol Sci Pract. 2023 May 11;2023(2):e202310. doi: 10.21542/gcsp.2023.10.

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.

PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.

Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies.

Heart Lung. 2023 May-Jun;59:173-180. doi: 10.1016/j.hrtlng.2023.02.003. Epub 2023 Feb 8.

Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases.

Biomol Biomed. 2023 Jul 3;23(4):546-567. doi: 10.17305/bb.2022.8779.

J Clin Med. 2022 Nov 26;11(23):6999. doi: 10.3390/jcm11236999.

Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature.

Int J Cardiol Heart Vasc. 2022 Dec;43:101154. doi: 10.1016/j.ijcha.2022.101154. Epub 2022 Nov 22.

本文引用的文献

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12.

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.

J Mol Cell Cardiol. 2020 Oct;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Epub 2020 Aug 20.

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).

JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.

Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.

J Am Coll Cardiol. 2020 Mar 10;75(9):1046-1057. doi: 10.1016/j.jacc.2020.01.036.

Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology.

Circulation. 2019 Jul 2;140(2):80-91. doi: 10.1161/CIRCULATIONAHA.118.034497.

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.

J Am Coll Cardiol. 2018 Dec 18;72(24):3158-3176. doi: 10.1016/j.jacc.2018.09.072.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献